Russian Direct Investment Fund (RDIF) expects the interim data on efficacy of Russia's Sputnik V coronavirus vaccine to be published in November, RDIF CEO Kirill Dmitriev said Monday
MOSCOW (Pakistan Point News / Sputnik - 09th November, 2020) Russian Direct Investment Fund (RDIF) expects the interim data on efficacy of Russia's Sputnik V coronavirus vaccine to be published in November, RDIF CEO Kirill Dmitriev said Monday.
"We also expect to publish interim efficacy data of Sputnik V clinical trials in November," Dmitriev said in a press release.
